Propylparaben

p-Hydroxybenzoic Acid Propyl Ester Market Intelligence Report (May 27, 2026)

I. Core Price Data
1. Benchmark Price Trend
- According to B2B platform Shengyishe, the benchmark price of p-hydroxybenzoic acid propyl ester (99% purity) was RMB 18,500 per metric ton in Hubei Province as of May 21, 2026 — unchanged from the quotation on May 9. Over the past month, prices have remained stable within the range of RMB 18,500–21,625 per metric ton.
- In Jiangsu Province, the quoted price stood at RMB 31,000 per metric ton (99% purity, Suzhou Senfeida Chemical Co., Ltd.), significantly higher than in Hubei, reflecting regional supply-demand imbalances and logistics cost differentials.

2. Upstream Raw Material Cost Transmission
- Fluctuations in upstream p-hydroxybenzoic acid prices:
- Hubei Province: RMB 18,500 per metric ton (as of May 22)
- Jiangsu Province: RMB 31,000 per metric ton (as of May 25)
- Upstream raw material prices have risen by 27% cumulatively over the past three years, sustaining persistent cost pressure on p-hydroxybenzoic acid propyl ester production.

II. Supply-Demand Landscape
1. Capacity & Output
- National annual production capacity has exceeded 12,000 metric tons, with the East China region (Jiangsu, Zhejiang, and Shandong provinces) accounting for 68% of total capacity. Leading enterprises include Zhejiang Huangma Technology Co., Ltd., Jiangsu Qiangsheng Functional Chemical Co., Ltd., and Shandong Jincheng Biochemical Co., Ltd.
- Stricter environmental regulations in 2025 led to the exit of seven small- and medium-sized enterprises (SMEs), each with annual capacity below 3,000 metric tons, from the food-grade market — further elevating industry concentration.

2. Consumption Structure
- Food Industry: Accounts for 55% of total demand; primarily used as a preservative in beverages, condiments, and meat products. Driven by the 'clean label' trend, some manufacturers are exploring synergistic (multi-component) formulations to reduce dosage levels.
- Cosmetics: Represents 30% of demand; fueled by the rise of domestic Chinese beauty brands and surging demand for functional skincare products, thereby accelerating penetration into premium formulations.
- Pharmaceuticals: Constitutes 15% of demand; employed in microbial contamination control for oral syrups, injectables, and topical ointments.

3. Regional Distribution
- East China Region: Accounts for 45% of national consumption, leveraging its mature industrial chain and export advantages to serve as the core consumption hub.
- South China Region: Accounts for 25% of consumption; benefits from Guangdong-Hong Kong-Macao Greater Bay Area biopharmaceutical industry policies, with steadily increasing coverage among pharmaceutical end-users.
- Southwest China Region: Accounts for 15% of consumption; regional players such as Sichuan Huanxu Biotechnology Co., Ltd. are gaining traction via competitive pricing strategies.

III. Regulatory & Industry Developments
1. Tightening Regulatory Oversight
- GB 2760-2024 has lowered the maximum allowable free phenol content limit to ≤0.15%, prompting enterprises to upgrade purification processes. High-purity products (≥99.5%) now exhibit enhanced technical barriers to entry.
- A proposed new restriction would prohibit use in infant complementary foods for infants aged 0–12 months, further constraining the food-grade application space.

2. Green Transformation
- The Ministry of Industry and Information Technology (MIIT) offers a 15% fixed-asset investment subsidy for continuous-flow microreactor technology and biocatalytic (enzyme-based) synthesis pathways; 12 enterprises have collectively secured RMB 328 million in technological upgrading funding.
- Solvent recovery rates across the industry now exceed 95%, significantly reducing waste acid discharge and aligning with China’s dual-carbon (carbon peak & carbon neutrality) goals.

3. Competitive Alternatives
- Bio-preservatives such as ε-polylysine and nisin are gaining market share; however, p-hydroxybenzoic acid propyl ester remains irreplaceable in acidic environments (pH 4–6.5) due to its superior efficacy and stability.

IV. Price Driver Analysis
1. Cost-Side Factors
- Sustained high prices for upstream p-hydroxybenzoic acid, coupled with volatility in auxiliary raw materials such as propanol, provide robust cost support.
- Environmental approval cycles have extended to 10–14 months, slowing the pace of new capacity deployment and limiting supply elasticity.

2. Demand-Side Factors
- Food industry demand remains relatively inelastic, yet administrative guidance promoting 'zero-additive' labeling continues to suppress incremental growth.
- Robust demand growth is evident in cosmetics and pharmaceutical applications — especially for premium and functionally enhanced formulations.

3. Policy-Side Factors
- Average customs clearance time for exports has lengthened to 8.7 working days; however, compliance-capable high-end production facilities demonstrate stronger pricing power, with export unit prices rising 9.4% year-on-year.
- Standardization work for green manufacturing evaluation systems is underway; while driving short-term cost increases, it enhances long-term competitiveness through technology upgrades.

V. Future Outlook
1. Price Trend Forecast
- Short Term (1–3 months): Prices are expected to remain stable in the range of RMB 18,500–21,000 per metric ton, supported by upstream costs and demand resilience.
- Medium Term (6–12 months): A potential decline in upstream p-hydroxybenzoic acid prices or new capacity coming online may lead to modest price adjustments downward to RMB 17,500–19,500 per metric ton.
- Long Term (1–3 years): Green transformation and technology upgrades will raise production costs, but premium-market pricing power is expected to strengthen — shifting the long-term price center upward to RMB 20,000–23,000 per metric ton.

2. Supply-Demand Structural Evolution
- Capacity: Green-production capacity is projected to surpass 60% of total installed capacity; industry concentration will further increase, with leading enterprises expanding their market shares.
- Demand: Growth in cosmetics and pharmaceutical applications (CAGR: 6–8%) is expected to outpace that in the food industry (CAGR: 2–3%), driving structural optimization toward higher-value segments.

3. Policy Impact Assessment
- If the proposed ban on use in infant complementary foods is formally implemented, food-grade demand could decline by ~5%; however, growth in cosmetics and pharmaceutical sectors is anticipated to partially offset this loss.
- Implementation of green manufacturing standards will accelerate the phase-out of outdated, inefficient capacity, ushering the industry into a high-quality development phase.